- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 26 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.5: 10 residues within 4Å:- Chain A: S.206, E.208, P.209, L.258, N.259, N.373, G.375, V.441, S.442
- Ligands: NAG.33
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:G.375
NAG-NAG-BMA-MAN-MAN.25: 10 residues within 4Å:- Chain E: S.206, E.208, P.209, V.251, N.259, N.373, G.375, V.441, S.442
- Ligands: NAG.52
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:G.375, E:V.441
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.30: 4 residues within 4Å:- Chain A: Q.127, S.147, F.148, N.149
Ligand excluded by PLIPNAG.31: 3 residues within 4Å:- Chain A: N.298, I.319, V.437
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: N.335, W.391
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain A: P.288, V.441, S.442, N.443
- Ligands: NAG-NAG-BMA-MAN-MAN.5
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain A: N.351
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain B: N.93, S.95
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain B: N.119, Y.120
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: S.147, F.148, N.149
Ligand excluded by PLIPNAG.38: 6 residues within 4Å:- Chain C: Q.290, N.292, N.328, V.329, S.330, R.439
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain C: N.298, I.319
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: N.335, W.391
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain C: N.259, P.288, N.443
- Ligands: NAG-NAG-BMA-MAN.16
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain C: N.133, N.134
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.351
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain D: N.93, S.95
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain D: N.100
- Chain H: X.51
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain D: K.115, E.116, N.119
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain E: N.130, T.132, R.140
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain E: S.147, F.148, N.149
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain E: N.298, I.319, V.437
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain E: N.335, W.391
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain E: Q.359, N.388
- Ligands: NAG-NAG.29, NAG-NAG.29
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain E: N.259, P.288, N.443
- Ligands: NAG-NAG-BMA-MAN-MAN.25
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain E: E.84, N.85
- Chain F: S.10
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain E: N.134, D.321
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain F: N.93, S.95
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain F: K.115, E.116, N.119
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Antanasijevic, A. et al., Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nat Commun (2021)
- Release Date
- 2021-08-04
- Peptides
- BG505 SOSIP MD39 - gp120: ACE
BG505 SOSIP MD39 - gp41: BDF
Rh.32034 pAbC-3 - Heavy Chain: G
Rh.32034 pAbC-3 - Light Chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DC
AE
CB
FD
BF
EG
HH
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 26 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 27 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Antanasijevic, A. et al., Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM. Nat Commun (2021)
- Release Date
- 2021-08-04
- Peptides
- BG505 SOSIP MD39 - gp120: ACE
BG505 SOSIP MD39 - gp41: BDF
Rh.32034 pAbC-3 - Heavy Chain: G
Rh.32034 pAbC-3 - Light Chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
DC
AE
CB
FD
BF
EG
HH
L